Brief: ChemoCentryx Inc Announces Approval In Japan Of Tavneos (Avacopan)
27/09/2021 14:07
Sept 27 (Reuters) - ChemoCentryx Inc CCXI.O :
* CHEMOCENTRYX ANNOUNCES APPROVAL IN JAPAN OF TAVNEOS™
(AVACOPAN)
FOR THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS
Source text for Eikon: ID:nGNX3shGp2
Further company coverage: CCXI.O
Recent news on Churchill Capital XI
See all newsBrief: AGCO To Pilot Digit Humanoid Robot At Hesston, Kansas Facility In 2027
Brief: Agility Robotics Announces Audit Committee Chair For Planned Public-Company Board
Brief: Agility Robotics And Churchill Capital Corp Xi S-4 Registration Statement Declared Effective By SEC In Connection With Proposed Business Combination
Brief: Agility And Fort Robotics Announce Strategic Partnership To Advance Humanoid Robot Safety
Deals of the day-Mergers and acquisitions